Lataa...
Inhibitors of Cyclin-Dependent Kinases as Cancer Therapeutics
Over the past two decades there has been a great deal of interest in the development of inhibitors of the Cyclin-dependent kinases (CDKs). This attention initially stemmed from observations that different CDK isoforms have key roles in cancer cell proliferation through loss of regulation of the cell...
Tallennettuna:
| Julkaisussa: | Pharmacol Ther |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6141011/ https://ncbi.nlm.nih.gov/pubmed/28174091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2017.02.008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|